MedTrace Logo

Feasibility Study of the JewelPump Version 3

NCT02097316 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2014-10-27

No results posted yet for this study

Summary

The study will be conducted, in cross-over with a time interval of at least 2 days between 2 treatment periods. Patients will be randomized into 2 groups According to the order of the randomization, patients will bear the JewelPump for 5 days, followed by a period of 5 days of treatment with their usual pumps.

Conditions

Interventions

DEVICE

JewelPump

DEVICE

usual insulin pump

Sponsors & Collaborators

  • Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

    lead OTHER

Principal Investigators

  • Sylvia FRANC, MD · Centre Hospitalier Sud Francilien

  • Nathalie JEANDIDIER, Pr. · University Hospital, Strasbourg, France

  • Denis RACCAH, Pr. · Centre Hospitalier Universitaire de Marseille

  • Guillaume CHARPENTIER, MD · Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02097316 on ClinicalTrials.gov